Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-27

FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for Dr. Reddy's to market amlodipine besylate and benazepril hydrochloride as a combination antihypertensive therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Benazepril Hydrochloride (Amlodipine besylate and benazepril hydrochloride)

Snippet

SUPPL AP for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)